Trial
NCT02927249
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
National Cancer Institute (NCI); United States Department of Defense; Bayer; Canadian Cancer Trials Group
Condition
Node Positive HER2 Negative Breast Cancer
Intervention
Placebo
Why stopped
DSMB review
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-04-05